Davide
Bello
GlaxoSmithKline (Spain)
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (Spain) (1)
2021
-
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial
Cell Chemical Biology, Vol. 28, Núm. 5, pp. 711-721.e8